From Clinical Care Options (CCO), watch a CME-certified video from a symposium at AASLD 2019 featuring expert perspectives on evolving systemic therapy for HCC
Clinical Care Options (CCO) downloadable patient resource guide to help patients and their caregivers manage their treatment for head and neck cancer.
Matthew Gubens, MD, MS, provides expert insight on frontline combination regimens using immunotherapy in advanced NSCLC.
Results from ATEMPT trial of adjuvant trastuzumab emtansine (T-DM1) and paclitaxel/trastuzumab (TH) in stage I HER2-positive BC from SABCS 2019 as reported by Clinical Care Options (CCO)
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.